Everaerts et al. demonstrated that mice lacking TRPV4 receptors or treated with HC-067047 (an antagonist of TRPV4) can preserve bladder capacity and remain free from urinary frequency, even in the presence of severe CYP-induced cystitis [42]. Here, PPIG is linked to cystitis.